Optimal interruption time of dabigatran oral administration to ablation (O-A time) in patients with atrial fibrillation: Integrated analysis of 2 randomized controlled clinical trials-Reference-Cited by-同舟云学术

Optimal interruption time of dabigatran oral administration to ablation (O-A time) in patients with atrial fibrillation: Integrated analysis of 2 randomized controlled clinical trials

Published:2021-06 Issue:6 Volume:77 Page:652-659
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Kimata Akira,Nogami Akihiko,Yamasaki Hiro,Ohigashi Tomohiro,Gosho Masahiko,Igarashi Miyako,Sekiguchi Yukio,Ieda Masaki,Calkins Hugh,Aonuma Kazutaka

Funder

Boehringer Ingelheim

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary;Calkins;Europace,2018

2. Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: evidence from a meta-analysis;Santangeli;Circ Arrhythm Electrophysiol,2012

3. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio;Di Biase;Circulation,2010

4. Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period;Wazni;Circulation,2007

5. Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation;Calkins;N Engl J Med,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Investigation on Anticoagulation Management Before and After Catheter Ablation for Atrial Fibrillation in Japan　― Periprocedural and Long-Term Outcomes ―;Circulation Journal;2022-12-23

2. JCS/JHRS 2021 Guideline Focused Update on Non-Pharmacotherapy of Cardiac Arrhythmias;Circulation Journal;2022-01-25

3. Procedural characteristics of pulmonary vein isolation with high-power short-duration setting compared to conventional setting;BMC Cardiovascular Disorders;2022-01-24

4. JCS/JHRS 2021 guideline focused update on non‐pharmacotherapy of cardiac arrhythmias;Journal of Arrhythmia;2022-01-07